‘ON TRACK WITH INTERNAL PIPELINES’

“Looking ahead, we will continue to strive for R&D excellence and build on the significant progress we have made in 2021. We remain firmly on track with our internal pipelines and will strategically choose to conduct research and development projects on other potential products as opportunities arise. In utilising our TDS technology platform, we will continue to deliver the outcome of contracted work for our clients in 2022.”

- CATHERINE LEE, Chief Scientific Officer, TAHO Pharmaceuticals, Taiwan